Intuitive Surgical Drops as ACA Changes, GLP-1s Weigh on Growth
AI Summary
Intuitive Surgical's shares dropped by as much as 13% after-market following slower growth in the use of its da Vinci surgical robots. The company maintained its procedure growth guidance despite the slowdown, affected by ACA changes and competition from GLP-1 drugs.
Intuitive Surgical shares fell as much as 13% in after-market trading as growth in use of its da Vinci surgical robots slowed to the weakest pace in four years and its guidance for procedure growth was unchanged.